Category Archives: Parkinson’s Treatment

Amarantus BioSciences Issues First Annual CEO Letter to Shareholders

SUNNYVALE, Calif., May 7, 2012 /PRNewswire/ — Amarantus BioSciences, Inc. (AMBS.OB), a biotechnology company developing the MANF Program for Parkinson’s Disease and other brain disorders, today released a letter from President & CEO Gerald E. Commissiong to its shareholders: OUR MISSION Healing Patients For those among us who operate in this volatile, uncertain and challenging field of development-stage biotechnology, it is critical that healing patients always remains the top priority in each challenge we face. Continue reading

Posted in Parkinson's Treatment | Tagged , , , , , , , | Comments Off

A breakthrough in Alzhemier's or Parkinson's treatment?

London, May 7 (IANS) Injecting a protein into the brain could protect its nerve cells from prion disease, a condition which causes the brain to wither away, says a new study. Continue reading

Posted in Parkinson's Treatment | Tagged , , , , , , , | Comments Off

New Peptide Therapy Stops Parkinson’s in Mice

By Rick Nauert PhD Senior News Editor Reviewed by John M. Grohol, Psy.D. Continue reading

Posted in Parkinson's Treatment | Tagged , , , , , , , | Comments Off

Parkinson’s Patients may Benefit from Lasik and Prelex Surgery

Corneal specialist Lasik vision expert, Dr. Rajesh Khanna asserts that Lasik and Prelex may greatly benefit patients suffering from Parkinson's disease. Parkinson's patients report having great results after surgery and no longer have to bother with the hassle of glasses or contacts.Los Angeles, CA (PRWEB) May 05, 2012 Corneal specialist Dr Continue reading

Posted in Parkinson's Treatment | Tagged , , , , , , , , , , , , , | Comments Off

Freezing Parkinson's in its tracks

Public release date: 2-May-2012 [ | E-mail | Share ] Contact: George Hunka ghunka@aftau.org 212-742-9070 American Friends of Tel Aviv University Parkinson’s disease, a disorder which affects movement and cognition, affects over a million Americans, including actor Michael J. Continue reading

Posted in Parkinson's Treatment | Tagged , , , , , , , , , , , | Comments Off

Vernalis up as Parkinson's drug passes safety trial

LONDON (ShareCast) – The drug development firm Vernalis (Frankfurt: A0RM65 – news) has reported a successful outcome in Phase I trials of its V81444 treatment that may be useful in the fight against Parkinson’s disease. The double-blind, placebo-controlled study showed “a wide range of doses were found to be well tolerated with no unexpected safety findings.” The focus now shifts to a “receptor occupancy” study, scheduled to start in the second half of 2012. Continue reading

Posted in Parkinson's Treatment | Tagged , , , , , , , | Comments Off

RBCC Target Amarantus BioSciences Reports Positive Pre-Clinical Results of Parkinson’s Treatment

NOKOMIS, Fla.–(BUSINESS WIRE)– Rainbow BioSciences, LLC, the biotech subsidiary of Rainbow Coral Corp. (OTCBB: RBCC.OB – News), announced today that its current joint venture target, Amarantus BioSciences, Inc., has achieved positive results in a pre-clinical experiment demonstrating the potential of its new Parkinsons disease therapy currently in development. Amarantus is the developer of MANF, a first-in-class, disease-modifying therapeutic protein that addresses an underlying form of cell death known as apoptosis Continue reading

Posted in Parkinson's Treatment | Tagged , , , , , , , , , , | Comments Off

Former Magic GM John Gabriel battling Parkinson's

Gabriel: “I feel good about things” John Gabriel was reading a magazine article when he noticed his ring finger quivering again. Continue reading

Posted in Parkinson's Treatment | Tagged , , , , , , , | Comments Off

What is Parkinson's disease?

Parkinson’s is a degenerative, neurological disorder that predominately affects movement. According to the National Parkinson Foundation, between 50,000 and 60,000 people are diagnosed with Parkinson’s every year. Continue reading

Posted in Parkinson's Treatment | Tagged , , , , , , , , , , , | Comments Off

Parkinson's Disease Neuropsychiatric Features And Fatigue Respond To Transdermal Rotigotine

Editor’s Choice Main Category: Parkinson’s Disease Article Date: 28 Apr 2012 – 6:00 PDT email to a friend printer friendly opinions Current Article Ratings: In the EU, Neupro (rotigotine) is approved for the treatment of the signs and symptoms of early-stage idiopathic Parkinson’s disease as a monotherapy, i.e. Continue reading

Posted in Parkinson's Treatment | Tagged , , , , , , , , , | Comments Off